Benzinga  Jun 10  Comment 
In an interview with Benzinga, Oragenics (NYSE: OGEN) CEO John Bonfiglio discussed the company’s business and opportunities that lie ahead. Bonfiglio started by explaining Oragenics’ most active business line: the development of a new...
SeekingAlpha  Apr 23  Comment 
By Trevor Lowenthal: With the growing problem of antibiotic resistance and the dire need for viable anti-infective therapies, we continue to investigate and report on antibiotic developers pioneering innovative technologies to address this public...
Benzinga  Jan 13  Comment 
Oragenics (NYSE MKT: OGEN) today announced that in view of the unusual market activity in the Company's stock, the NYSE MKT has contacted the Company in accordance with its usual practice. The Company stated that its policy is not...
Benzinga  Oct 1  Comment 
Oragenics, Inc. (NYSE: OGEN), a leader in the development of novel, effective antibiotics and oral care probiotics, and Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the establishment of an Exclusive...
StreetInsider.com  Sep 27  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Stock+Splits/Oragenics+%28ORNI%29+announces+1-for-20+reverse+stock+split/5999449.html for the full story.
Sydney Morning Herald  Mar 6  Comment 
The Open Net Initiative (ONI) on Friday said Microsoft's search engine Bing is more prudish than government censors when it comes to sex-related online queries.
Cloud Computing  Sep 9  Comment 
Clearswift, das in Großbritannien ansässige Unternehmen für Informationssicherheit, hat mit ONI, dem portugiesischen Anbieter von Kommunikationslösungen, einen Vertrag abgeschlossen, um den Geschäftskunden von ONI seine...


Hi Marcel,Thanks for your offer we love to get beta testers! We are some way off pzeaonslierd dashboards, but we might have an export to SD in the interim. We'll update the blog when we have more info.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki